P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMAChris Meulenbroeks, M Kool, C. Giebel et al.|Neuro-Oncology|2025Cited by 0